Trade Summary
3 days ago, Townsend Richard Nolan, serving as CEO at Lexeo Therapeutics, Inc. (LXEO), sold 10,173 shares at $6.38 per share, for a total transaction value of $64,924.00. Following this transaction, Townsend Richard Nolan now holds 392,483 shares of LXEO.
This sale represents a 3.00% decrease in Townsend Richard Nolan's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 20, 2026, 2 days after the trade was made.